Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2

Virology

Volumn 235, Issue 2, 1997, Pages 293-301

  Zhang, Suhua ^a   Racaniello, Vincent R ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ECHO VIRUS; GENE EXPRESSION; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALIA; ECHOVIRUS; ENTEROVIRUS; HUMAN ECHOVIRUS 1; POLIOVIRUS;

EID: 0030772723     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8692     Document Type: Article

References (34)

1. Benton P. A., Barrett D. J., Matts R. L., Lloyd R. E. The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J. Virol. 70:1996;5525-5532.
2. Benton P. A., Murphy J. W., Lloyd R. E. K562 cell strains differ in their response to poliovirus infection. Virology. 213:1995;7-18.
3. Bergelson J. M., Shepley M. P., Chan B. M. C., Hemler M. E., Finberg R. W. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science. 255:1992;1718-1720.
4. Bergelson J. M., St. John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., Finberg R. W. Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J. Virol. 67:1993;6847-6852.
5. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbere-Garapin F. Persistent poliovirus infection: Establishment and maintenance involve distinct mechanisms. Virology. 186:1992;398-408.
6. Borzakian S., Pelletier I., Calvez V., Colbere-Garapin F. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:1993;2914-2917.
7. Carrasco L. Modification of membrane permeability by animal viruses. Adv. Virus Res. 45:1995;61-112.
8. Clark E. A., Brugge J. S. Integrins and signal transduction pathways: the road taken. Science. 268:1995;233-239.
9. Colbere-Garapin F., Christodoulou C., Crainic R., Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 86:1989;7590-7594.
10. Coller B.-A. G., Chapman N. M., Beck M. A., Pallansch M. A., Gauntt C. J., Tracy S. M. Echovirus 22 is an atypical enterovirus. J. Virol. 64:1990;2692-2701.
11. Cunningham L., Bowles N. E., Lane R., Dubowitz V., Archard L. C. Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J. Gen. Virol. 71:1990;1399-1402.
12. Gibson J., Righthand V. F. Persistence of echovirus 6 in cloned human cells. J. Virol. 54:1985;219-223.
13. Joklik W. Summary of mechanisms involved in persistent infections. Microbiology-1977. 1977;Am. Soc. Microbiol. Washington. p. 434-438.
14. Kaplan G., Levy A., Racaniello V. R. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J. Virol. 63:1989;43-51.
15. Kaplan G., Racaniello V. R. Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection. J. Virol. 65:1991;1829-1835.
16. King S. L., Cunningham J. A., Finberg R. W., Bergelson J. M. Echovirus 1 interaction with the isolated VLA-2 I domain. J. Virol. 69:1995;3237-3239.
17. Kit S., Dubbs D. R., Piekarki L. J., Hsu T. C. Deletion of thymidine kinase activity from L cells resistant to bromodeoxyuridine. Exp. Cell Res. 31:1963;297-312.
18. Klingel K., Honenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA. 89:1992;314-318.
19. Lloyd R., Bovee M. Persistent infection of human erythroblastoid by poliovirus. Virology. 194:1993;200-209.
20. Lopez-Guerrero J. A., Carrasco L., Martinez-Abarca F., Alonso M. A. Restriction of poliovirus RNA translation in a human monocytic cell line. Eur. J. Biochem. 186:1989;577-582.
21. Melnick J. L. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses. Fields B. N. Fields Virology. 1996;655-712 Lippincott-Raven, Philadelphia.
22. Mendelsohn C., Wimmer E., Racaniello V. R. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell. 56:1989;855-865.
23. Morrison M. E., He Y.-J., Wien M. W., Hogle J. M., Racaniello V. R. Homolog-scanning mutagenesis reveals polivirus residues important for virus binding and replication. J. Virol. 68:1994;2578-2588.
24. Okada Y., Toda G., Oka H., Nomoto A., Yoshikura H. Poliovirus infection of established human blood cell lines: Relationship between the differentiation stage and susceptibility or cell killing. Virology. 156:1987;238-245.
25. Pavio N., Buc-Caron M., Colbere-Garapin F. Persistent poliovirus infection of human fetal brain cells. J. Virol. 70:1996;6395-6401.
26. Pelletier I., Coulderc T., Borzakian E., Wyckoff E., Crainic R., Ehrenfeld E., Colbere-Garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology. 180:1991;729-737.
27. Racaniello V. R., Baltimore D. Studies on poliovirus produced by transfection with cloned viral cDNA. Ahmad F., Schultz J., Smith E. E., Whelan W. J. From Gene to Protein: Translation into Biotechnology. 1982;459-470 Academic Press, New York.
28. Righthand V. F., Blackburn R. V. Steady-state infection by echovirus 6 associated with nonlytic viral RNA and an unprocessed capsid polypeptide. J. Virol. 63:1989;5268-5275.
29. Rueckert R. R. Picornaviridae: The viruses and their replication. Fields B. N. Fields Virology. 1996;609-654 Lippincott-Raven, Philadelphia.
30. Sharief M. K., Phil M., Hentges R., Ciardi M. Intrathecal immune response in patients with the post-polio syndrome. N. Engl. J. Med. 325:1991;749-755.
31. Swanson N. R., Fox S. A., Mastaglia F. L. Search for persistent infection with poliovirus or other enteroviruses in amyotrophic sclerosis-motor neuron disease. Neuromuscular Disorders. 5:1995;457-465.
32. Walker D. L. The viral carrier state in animal cell cultures. Prog. Med. Virol. 6:1964;111-148.
33. Wolff D. A., Bubel H. C. The disposition of lysosomal enzymes as related to specific viral cytopathic effects. Virology. 24:1964;502-505.
34. Wyss-Corey T., Masliah E., Rockenstein E. M., Brooker M. J., Lee H. S., Mucke L. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97:1996;789-798.